Olukotun Adeoye Y — insider trades

Olukotun Adeoye Y (Director at ARROWHEAD PHARMACEUTICALS, INC.) reported stock trades on SEC Form 4 at ARWR ARROWHEAD PHARMACEUTICALS, INC..

Since December 2024, Olukotun Adeoye Y reported 4 sales worth $928K. In the last 12 months: sold $851K. 3 of the 4 sales were made under pre-arranged 10b5-1 trading plans.

Olukotun Adeoye Y's trades in ARWR ARROWHEAD PHARMACEUTICALS, INC.

Role: Director. 31,600 shares owned after the sale on Aug 18, 2026. ARWR ARROWHEAD PHARMACEUTICALS, INC. · ARWR stock overview

• Aug 18, 2026: sold 2,000 shares at $86.96 ($174K), 31,600 shares after
• Dec 19, 2025: sold 10,000 shares at $67.66 ($677K), 33,600 shares after · 10b5-1 plan
• Jan 23, 2025: sold 959 shares at $21.00 ($20.1K), 35,781 shares after · 10b5-1 plan
• Dec 27, 2024: sold 2,850 shares at $20.00 ($57.0K), 36,740 shares after · 10b5-1 plan

Planned sales by Olukotun Adeoye Y (Form 144)

• Filed Dec 19, 2025: plans to sell 10,000 shares of ARWR Arrowhead ($677K)

Is Olukotun Adeoye Y buying or selling?

Olukotun Adeoye Y's most recent open-market trade was a sale of 2,000 shares of ARWR ARROWHEAD PHARMACEUTICALS, INC. on August 18, 2026, worth $174K.

What is Olukotun Adeoye Y's role at ARROWHEAD PHARMACEUTICALS, INC.?

Olukotun Adeoye Y reports as Director of ARROWHEAD PHARMACEUTICALS, INC. on SEC Form 4.

How many ARWR shares does Olukotun Adeoye Y own?

Olukotun Adeoye Y reported owning 31,600 shares of ARROWHEAD PHARMACEUTICALS, INC. after the sale on August 18, 2026.